{"title":"Development of a selective COX-2 inhibitor: from synthesis to enhanced efficacy via nano-formulation","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA06295G","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA06295G\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,32721-32732<br /><b>DOI</b>: 10.1039/D4RA06295G, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Marwa Elewa, Mohamed Shehda, Pierre A. Hanna, Mohamed M. Said, Sherif Ramadan, Assem Barakat, Yasmine M. Abdel Aziz<br />This study designs novel 2-benzamido-<em>N</em>-(4-substituted phenyl)thiophene-3-carboxamide derivatives as selective COX-2 inhibitors. Compound <strong>VIIa</strong> showed strong <em>in vitro</em> anti-inflammatory activity, and incorporating it into niosomes improved its release profile for future <em>in vivo</em> use.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"895d81c48543bc25e020f530a55f7bc93dc568fe107f538c2803d9de35555865","category":"Environment"}